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Abstract
This review considers the role of bacterial antizyme in the regulation of polyamine biosynthesis and
gives new perspectives on the involvement of antizyme in other significant cellular mechanisms.
Antizyme is a protein molecule induced by the end product of the enzymic reaction that it inhibits,
in a non-competitive manner. The bacterial ornithine decarboxylase is regulated by nucleotides,
phosphorylation and antizyme. The inhibition of ornithine decarboxylase by antizyme can be
relieved to different degrees by DNA or by a variety of synthetic nucleic acid polymers, attributed
to a specific interaction between nucleic acid and antizyme. Recently, this interplay between
bacterial antizyme and nucleic acid was determined by discerning an additional function to antizyme
that proved to be the atoC gene product, encoding the response regulator of the bacterial two-
component system AtoS-AtoC. The gene located just upstream of atoC encodes the sensor kinase,
named AtoS, that modulates AtoC activity. AtoC regulates expression of atoDAEB operon which
is involved in short-chain fatty acid metabolism. Antizyme is thus referred to as AtoC, functioning
both as a post-translational and transcriptional regulator. Also, the AtoS-AtoC signal transduction
system in E. coli has a positive regulatory role on poly-(R)-3-hydroxybutyrate biosynthesis. The
properties and gene structural similarities of antizymes from different organisms were compared.
It was revealed that conserved domains are present mostly in the C-domain of all antizymes. BLAST
analysis of the E. coli antizyme protein (AtoC) showed similarities around 69–58% among
proteobacteria, g-proteobacteria, enterobacteria and the thermophilic bacterium Thermus
thermophilus. A working hypothesis is proposed for the metabolic role of antizyme (AtoC)
describing the significant biological implications of this protein molecule. Whether antizymes exist
to other enzymes in different tissues, meeting the criteria discussed in the text remains to be
elucidated.
Review
In 1978 Seymour Cohen, the father of the field of
polyamines posed the question "what do the polyamines
do?" in his excellent article [1]. Since then, thousands of
papers appeared in the literature concerning the meta-
bolic role of polyamines. We will not attempt to discuss
all the recent progress in the field, which has been well
documented in book form [2-8] as well as in a number of
excellent reviews [9-15]. Instead, we shall only consider
the role of antizyme (Az) in the regulation of ornithine
decarboxylase (L-ornithine carboxylyase, EC 4.1.1.17,
ODC), its involvement in the bacterial two-component
signal transduction system AtoS-AtoC [16], as well as its
implication in other significant cellular functions.
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Az was discovered by Canellakis and co-workers in rat
liver and several cell lines. It is a 26.5 kDa protein,
induced by polyamines, the product of ODC action. Az
forms complex with ODC, inhibiting that way the enzyme
activity in a stoichiometric manner, non-competitively
[17,18]. The inactive ODC-Az complex can be dissociated
by high salt concentrations. The induction of Az by exog-
enously added polyamines is inhibited by cycloheximide
or puromycin, but not by actinomycin D indicating that
polyamines induce antizyme by stimulating the transla-
tion of its mRNA [13]. This explains an old paradoxical
finding that ODC activity was stimulated in rat liver when
puromycin was administered to animals [19].
Since then, three different Azs have been identified in
eukayotic cells, possessing different roles at the cellular
levels: a) Az1 inhibits ODC and then directs its degrada-
tion by the 26 S proteosome. ODC when bound to Az1 is
efficiently degraded by the proteosome and Az1 is usually
recycled to act again [13,20]. This type of degradation of
ODC usually occurs in an ATP-dependent, but ubiquitin-
independent manner. Polyamines can trigger a +1 transla-
tional frameshift on Az mRNA, allowing the complete Az1
protein to be expressed [13,21]. ODC can be released
from Az1 by another protein called "anti-antizyme",
which liberates ODC in the presence of growth stimuli
having higher affinity for Az1 than for ODC [22]. b) Az2
shares similar properties with Az1, including the regula-
tory frameshifting. It does not stimulate, however, degra-
dation of ODC under certain conditions, but alters
polyamine homeostasis, by down-regulating polyamine
uptake independently of the effects on ODC, thus playing
a negative role in the regulation of polyamine transport
[23,24]. c) Az3 is expressed to a limited extend in testis
germ cells, at a particular stage of spermatogenesis
[25,26]. The pattern of Az3 expression suggests that it acts
by sharply limiting polyamine accumulation in cells that
have finished DNA synthesis and meiotic reduction and
are about to be remodeled into mature spermatozoa [25].
Searches on genomic databases have revealed that the Azs
comprise a widespread family of conserved homologues
[27]. In humans, five non-allelic Az homologues have
been detected. Two copies are presented in zebra fish
Danio rerio. Az has also been cloned from fruit flies (Dro-
sophila melanogaster and Drosophila virillis) and is found in
a number of invertebrate species (Bombyx mori, Caenorhab-
ditis elegans, Onchocerca volvulus, Haemonchus contortus and
Pristionchus pacificus). Moreover, Az activity has been
detected in a wide variety of organisms, from plants to
eubacteria [8,9,14,15,23-32].
The question is why a cell or an organism needs more
than one type of Az with distinct functions? Their distinct
functions may be due to their special time of expression,
compartmentalization or different place and way of deg-
radation of ODC.
Regulation of polyamine biosynthesis in bacteria
Regulation of ODC allosterically by nucleotides
Two ODCs, the biosynthetic and the biodegradative have
been characterized in E. coli [33,34]. The biodegradative
ODC is induced by low pH and by the presence of orni-
thine in the growth medium. The activity of the biosyn-
thetic ODC is modulated by a number of positive and
negative effectors [11]. The positive effectors include
nucleotides, GTP being the more effective [34], while
ppGpp acts as a negative effector [35]. The requirement
for GTP in protein synthesis and the accumulation of
ppGpp during starvation of E. coli that are under stringent
control, suggest that changes in polyamine pools may be
responsible for the stringent effect in E. coli [35]. The accu-
mulation of ppGpp leads to the cessation of stable RNA
synthesis and appears to have a bearing on the fidelity of
protein synthesis [36]. Treating recombinant ODC with
calf intestine alkaline phosphatase leads to inactivation of
ODC that can be allosterically reversed only by guanosyl
or uridyl phosphate analogues at a concentration of 10-4
or 10-3 M [37]. Nucleotides are effective in activating
ODC, in the order (G,U)TP>(G,U)DP>(G,U)MP. [8-
3H]GTP binds specifically to ODC since cold GTP but not
ATP can dissociate the radioactive analogue. High concen-
tration of GTP can dissociate the ODC-Az complex and
either reactivate or liberate ODC [37].
Regulation of ODC by phosphorylation
Biosynthetic ODC of E. coli can be phosphorylated both
in vivo as well as in vitro [37]. An ODC-phosphorylating
kinase was purified from middle-log growing E. coli K-12
strain MG1655, containing plasmid pODC [38]. The
kinase requires 10 mM Ca++ for optimal activity.
In vivo phosphorylation of ODC
E. coli K-12 strain MG 1655+pODC, was labeled in vivo
with [32P] orthophosphate, ODC was immunoprecipi-
tated by ODC antibody and proteins were then analyzed
by SDS-PAGE followed by autoradiography. In the auto-
radiogram one radioactive band appeared at 82 kDa, cor-
responding to the Mr of the subunit of the biosynthetic
ODC [37].
In vitro phosphorylation of ODC
The in vitro phosphorylation of ODC depends on the state
of phosphorylation of the ODC molecule [37]. Therefore,
the difficulties of the negative data on the ODC phospho-
rylation in different bacterial systems can be explained by
the above observation. A partially purified kinase from E.
coli was capable to phosphorylate the dephosphorylated
preparation of ODC (ODCb). This was the first indicationPage 2 of 9
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in bacteria.
Regulation of ODC by Az
Two macromolecular effectors of ODC were identified in
the ODC- E. coli mutant, MA255 [28]. One was an inhibi-
tor of ODC, with characteristics similar to the Az of
eukaryotic cells. It was a noncompetitive inhibitor of
ODC; its complex with ODC could be dissociated with
salt to yield active ODC and active ODC inhibitor. This E.
coli inhibitor also inhibited ODC activity of eukaryotic
cells. The other effector was a thermostable, nondialyza-
ble molecule that activated the ODC of E. coli 6- to 7-fold.
Similar macromolecular inhibitors and activators have
been identified in the parent ODC+ strain, MA197. Those
results suggested that ODC activity might be controlled
post-translationally by positive and negative macromo-
lecular effectors whose intracellular levels also fluctuate in
response to the extracellular putrescine, the end product
of the ODC reaction [28].
The mode of Az induction
The induction of macromolecular inhibitors of ODC by
putrescine, spermidine, and spermine, as well as by other
diamines, has been now amply verified by a number of
laboratories, which has been reviewed elsewhere [9,15].
Initial attempts to demonstrate the existence of Az, by
mixing extracts, each of which had ODC activity failed
[39]. The reasons of failure which have been presented in
detail [40], rest upon the fact that the bound inhibitor
cannot be assayed by activity measurements. Only excess
or free unbound inhibitor can be assayed by such mixing
experiments; therefore, in order to assay for free Az, the
test sample should have no measurable ODC activity.
Following the published methodology from Canellakis'
laboratory for the induction of Az [9,17,18,28], extensive
purifications of rat liver and of E. coli Az have been accom-
plished [9]. Increasing concentrations of diaminooctane
progressively inhibit ODC activity and eventually produce
free assayable ODC antizyme. Since diaminooctane is an
analogue of spermidine-compare
NH2(CH2)3NH(CH2)4NH2 and NH2(CH2)8NH2- a possi-
ble explanation is that the very low concentrations of
diaminooctane compete for certain spermidine sites and
release the inhibition exerted by spermidine; the higher
diaminooctane concentrations then inhibit ODC activity
through the production of Az, as do all diamines and
polyamines that have been tested [9,40].
The evidence in favor of Az participating, at least in part,
in the regulation of ODC is as follows:
a) Free Az can be induced by 10-7 – 10-6 M putrescine in
cells that have been depleted of ODC activity. Originally,
it was necessary to use higher concentrations of putrescine
in order to elicit free Az in cells that either contained ODC
activity or were being induced concurrently for ODC
activity. Higher concentrations of the inducer were
required, because large amounts of Az were necessary to
neutralize the existing intracellular ODC activity [40].
b) Az is a normal component of the nuclei and sub cellu-
lar particles of uninduced rat liver cells [41,42].
c) Putrescine also induces an Az in E. coli, which cross-
reacts with rat liver ODC and functions like the eukaryotic
Az1 [28,29].
Overproduction of Az by E. coli transformed with a plas-
mid carrying the Az gene is inhibitory to ODC and ADC
(arginine decarboxylase). Indeed the ODC of an inacti-
vated ODC-Az complex can be reactivated by the addition
of ADC; the converse also occurs [43]. This technique ena-
bles the demonstration of much inactive ODC and ADC
in E. coli extracts.
Reversal of Az inhibition by nucleic acids
Huang et al. [44] found that the inhibition of E. coli ODC
by Az from the same source is relieved to different degrees
by DNA and by a variety of synthetic nucleic acid poly-
mers, including ribo- and deoxyribo-nucleotide polymers.
Preferences for certain nucleic acid sequences were
observed. The inhibition of rat liver ODC by the E. coli Az
was also relieved by nucleic acids.
The ability of E. coli genomic DNA or other nucleic acids
to relieve the inhibition of ODC by the acidic Az [28] was
originally attributed to possible binding of Az to certain
sequences of DNA [45]. For this reason the relief of the Az
inhibition of ODC activity was used as an assay of the rel-
ative effectiveness of various nucleic acid sequences. Fur-
thermore, the relative effectiveness of single-stranded
deoxynucleotide and ribonucleotide homopolymers in
relieving the inhibition of E. coli ODC by Az was com-
pared. Since both the acidic Az and the nucleic acids are
negatively charged at the assay pH, these interactions
could not be ascribed to charge effects alone. Moreover,
the nucleic acids were not equivalent in their abilities to
relieve the inhibition of ODC by antizyme. The differ-
ences in the degree of relief of inhibition exerted by vari-
ous segments of E. coli DNA, suggested that there was a
specificity of interaction between nucleic acids and Az.
The main property that differentiates Az from many of the
double or single-stranded DNA or RNA binding proteins
is that Az also binds and inhibits ODC and subsequently,
upon its binding to DNA, this inhibition of ODC is
reversed.Page 3 of 9
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and nucleic acids has been determined by attributing an
additional physiological function to Az, that of the
response regulator of the bacterial two-component signal
transduction system AtoS-AtoC regulating expression of
atoDAEB operon encoded enzymes [16,46-53].
The two-component regulatory system AtoS-AtoC
The E. coli Az gene has been identified and found to share
significant homology with bacterial transcriptional activa-
tors of the two-component regulatory system family [16].
These systems consist of a "sensor" kinase and a response
regulator, which often is a transcriptional factor [54-56].
By sensing an appropriate signal, the sensor kinase auto-
phosphorylates on a histidine residue. Following physical
contact of the phosphorylated sensor kinase with the
response regulator, the phosphoryl group is transferred,
usually to an aspartate residue of the response regulator,
which leads to its activation.
Recently, it has been reported that Az is the atoC gene
product [47,48,53] possessing a second function as the
regulator of the expression of genes encoding enzymes
involved in short chain fatty acid metabolism (atoDAEB
operon) [49-51]. Today, the protein is referred to as AtoC,
functioning both as a transcriptional and post-transla-
tional regulator. The gene located just upstream of atoC
encodes the sensor kinase that modulates AtoC activity
[16] and has since been named atoS, to reflect the role of
its product, AtoS, as a sensor kinase [48,52,53]. Recently,
direct biochemical data have been obtained proving that
the gene products of atoS and atoC constitute a two-com-
ponent signal transduction system involved in the regula-
tion of the atoDAEB operon [46]. Moreover, the DNA
binding sequences of AtoC on atoDAEB operon promoter
have been determined [46,57]. Thus, the novel physiolog-
ical function that has been ascribed to bacterial Az (AtoC)
as a transcriptional regulator is in accordance with Az's
DNA specific binding on the E. coli genome and can
clearly explain the fore mentioned data describing the
relief of ODC inhibition upon Az binding to DNA.
The role of the AtoS-AtoC signal transduction system in E.
coli on the positive regulation of the levels of poly-(R)-3-
hydroxybutyrate (PHB) biosynthesis has been recently
identified [58]. Increased amounts of PHB are synthesized
in E. coli upon exposure of the cells to acetoacetate, the
inducer of the AtoS-AtoC two-component signal transduc-
tion system, when both components of the system are
overproduced (our unpublished data).
A recent transcriptome analysis of the E. coli two-compo-
nent systems [59] revealed possible roles, positive and/or
negative, of the AtoS-AtoC system in a number of proc-
esses including flagellar synthesis and chemotactic behav-
iour of E. coli. The same study also highlights the interplay
between two-component systems, as mutations in the
ompR-envZ system were also found to affect the expression
of atoC. Moreover, a phenotype microarray analysis of E.
coli mutants with deletions of all two-component systems
showed that atoSC mutants presented susceptibility to
specific osmolarity conditions, some membrane agents,
aminoglycoside and a respiration inhibitor indicating
other putative roles for the two-component system under
study [60].
Gene structural analysis of antizymes
Eukaryotic Az genes require ribosomal frame shifting for
their expression. Twelve nucleotides around the frame
shift site are identical between S. pombe and the mamma-
lian counterparts. The core element for this frame shifting
is likely to have been present in the last common ancestor
of yeast, nematodes and mammals [24], but not in E. coli
[61]. The existence of homology between the mammalian
antizymes, Az-1, -2 and -3, and the bacterial antizyme
AtoC was more thoroughly investigated. It was revealed
that conserved domains are present at the C-terminal
parts of all antizymes (data obtained and will appear
shortly) as it has been similarly reported for the S. pombe
counterpart [62]. This region is responsible for binding
and inactivating ODC, while it cannot accelerate its degra-
dation by the 26S proteosome [13,20]. AtoC was found to
belong to the NtrC-NifA family of sigma54-RNA polymer-
ase transcriptional activators [52], while it presents 40%
identities and 58% positives with the E. coli NtrC tran-
scriptional regulator [63-67]. The E. coli AtoC protein
which has been biochemically characterized [46] was
found to have homologues in the proteobacteria, g-pro-
teobacteria and enterobacteria as indicated by BLAST
analysis [68-88], while an AtoC homologue was also
present in T. thermophilus, whose complete genome anal-
ysis was recently published [69] [Table 1]. The latter is in
agreement with previous biochemical data reporting the
presence of antizyme activity in T. thermophilus [31].
BLAST analysis also indicated that AtoC structurally com-
prises three conserved domains, i.e. the N-terminal
receiver domain containing the phosphorylation site, the
central sigma54 interaction domain and the C-terminal
DNA-binding domain.
A working hypothesis for the metabolic role of Az (AtoC)
A working hypothesis for the bacterial Az (AtoC) role and
the cascade of reactions that are triggered by its activation/
induction is shown in Fig. 1. Acetoacetate or its metabolic
counterpart acetoacetyl-CoA, is the signal upon which the
kinase AtoS is autophosphorylated [49-52,46]. Subse-
quently, the phosphoryl group is transferred by protein-
protein interaction to the response regulator AtoC. AtoC is
thus activated and able to bind to the atoDAEB operon
promoter at two "dyad symmetry" sequences [46], as itPage 4 of 9
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Locus or Accession No Genome annotation Microorganism
[Taxa]
Hitsa Id./Sim.b(%/%) Ref.
Q06065 ATOC ECOLI Acetoacetate metabolism regulatory protein 
atoC (Ornithine/arginine decarboxylase 
inhibitor) (Ornithine decarboxylase 
antizyme)
Escherichia coli K12 
[enterobacteria]
2 95/95 16, 47, 48, 70
NP 754649.1 Acetoacetate metabolism Regulatory protein 
atoC
Escherichia coli CFT073 
[enterobacteria]
3 95/95 71
ZP 00015409.1 COG2204: Response regulator containing 










NP 972572.1 sigma-54 dependent transcriptional 
regulator/response regulator
Treponema denticola ATCC 
35405 [spirochetes]
1 44/64 74
ZP 00079669.1 COG2204: Response regulator containing 





YP 012430.1 sigma-54 dependent transcriptional 
regulator/response regulator
Desulfovibrio vulgaris subsp. 
vulgaris str. Hildenborough 
[d-proteobacteria]
5 43/61 75
NP 218960.1 response regulatory protein (atoC) Treponema pallidum subsp. 
pallidum str. Nichols 
[spirochetes]
1 43/63 76
AAQ63912.1 mutant NtrC-like activator Myxococcus xanthus [d-
proteobacteria]
8 44/62 77
YP 008363.1 probable two-component response 
regulator
Parachlamydia sp. UWE25 
[chlamydias]
1 44/62 78
ZP 00128642.1 COG2204: Response regulator containing 





NP 968400.1 regulator protein pilR Bdellovibrio bacteriovorus 
HD100 [d-proteobacteria]
3 40/63 79
AAL27375.1 HydG Yersinia pestis 
[enterobacteria]
1 43/62 80
NP 709798.1 response regulator of hydrogenase 3 activity 
(sensor HydH)
Shigella flexneri 2a str. 301 
[enterobacteria]
2 44/61 81
NP 992358.1 Response regulator containing CheY-like 
receiver, AAA-type ATPase and DNA-
binding domains
Yersinia pestis biovar 
Medievalis str. 91001 
[enterobacteria]
1 43/63 82
NP 290636.1 response regulator of hydrogenase 3 activity 
(sensor HydH)
Escherichia coli O157:H7 
EDL933 [enterobacteria]
2 44/60 83
NP 243814.1 two-component response regulator in 
acetoacetate metabolism
Bacillus halodurans C-125 
[eubacteria]
1 41/62 84
Q9APD9 ZRAR KLEOX Transcriptional regulatory protein zraR Klebsiella oxytoca 
[enterobacteria]
1 43/61 85
NP 312817.1 GlnG; response regulator for gln Escherichia coli O157:H7 
[enterobacteria]
1 40/58 86
P25852 ZRAR SALTY Transcriptional regulatory protein zraR Salmonella typhimurium LT2 
[enterobacteria]
2 43/60 87
NP 458044.1 Two-component system, response regulator Salmonella enterica subsp. 
enterica serovar Typhi str. 
CT18 [enterobacteria]
2 40/58 88
YP 005107.1* two-component response regulator Thermus thermophilus HB27 
[eubacteria]
22 33/58 69
aHits: Number of homologues found in each microorganism (only the one with the highest homology is presented). bId./Sim.: Identities/Similarities. 
* The E. coli K-12 atoC gene was aligned against the T. thermophilus genome independently since its homology was not detected among the first 100 
best BLAST hits (threshold 0.005).Page 5 of 9
(page number not for citation purposes)
Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/8has been reported for the NtrC response regulator [63-
67]]. Thereafter, AtoC is probably oligomerized, a process
that triggers its ATPase activity (our unpublished data).
Upon ATP hydrolysis, the "closed" form of the RNA-
sigma54 holoenzyme is transformed into an "open" form
[67]. The activated open form is able to induce atoDAEB
operon transcription which leads to short chain fatty acid
catabolism and activation of the PHB biosynthetic path-
way, via the AtoDA molecule (acetoacetyl-CoA trasn-
ferase) [58, our unpublished data]. A functional AtoS-
AtoC system has also been reported to affect E. coli chem-
otactic behavior [59], while some other putative roles are
still under investigation [60]. AtoC whose production is
stimulated by polyamines in E. coli as well, plays a central
role in ODC regulation by binding to ODC and inhibiting
it non-competitively [28]. We still don't know whether
the ODC inhibiting activity of AtoC/Az is activated upon
AtoC/Az phosphorylation and thus affected by the two-
component system under study. Moreover, native ODC
can be reversibly inactivated by a dephosphorylation-
phosphorylation reaction. Therefore, phosphorylation of
the bacterial ODC is one of the possible regulating mech-
anisms for this enzyme, as was proved for the mammalian
and protozoan ODC [15,37]. Finally, nucleotides can
convert allosterically the inactive, phosphorylated ODCb
to an active form of ODCb, suggesting that nucleotides
may be physiological regulators of ODC in E. coli. Active
ODC can be recovered from the ODC-Az complex by high
concentrations of salts, DNA or GTP [28,37,44].
The involvement of antizyme (AtoC) in various regulatory mechanisms in E. coliFigure 1
The involvement of antizyme (AtoC) in various regulatory mechanisms in E. coli.Page 6 of 9
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The antizyme may constitute part of a normal control
mechanism that defines the levels of ODC activity. How-
ever, it is a noncompetitive protein inhibitor and cannot
be detected in free form when there is measurable ODC
activity. Consequently, to prove the participation of the
Az in the normal control of ODC, methodology has been
developed permitting the isolation of the ODC-Az com-
plex, separation of the complex into the component parts
and assaying the respective activities [9,28,29].
We do know that the cell will produce free Az in the pres-
ence of high diamine or polyamine concentrations. Under
these conditions, the tissue culture cells are in a relatively
"unhappy" state; in the rat, the amount of putrescine
required to elicit high levels of Az makes the animal
extremely sick. Consequently, in the search for Azs to
other enzymes, we believe the following criteria should be
kept in mind:
1. The product should be added in high enough concen-
trations so that no enzyme activity can be detected.
2. The inhibition should be maintained over relatively
long periods of time to maximize the amount of Az.
3. Inhibition, by the protein which will be induced by the
end product of the enzymic reaction must be of a non-
competitive manner.
We believe that under these extreme conditions the cell is
responding to the excess product by what may be its last
available defense mechanism producing additional non-
competitive inhibitory proteins to neutralize the enzyme
in order to lower the level of the product. So far, not any
antizyme to other enzyme has appeared in the literature.
The above question needs to be addressed at the biochem-
ical as well as genetic level.
Conclusions and future directions
This review has evaluated some of the information availa-
ble for the ornithine decarboxylase antizyme and has
attempted to summarize the regulatory mechanisms in
which it may be involved. Our understanding of the func-
tions of Az derives from different biological sources. In
eukaryotes three antizymes have been detected: i) Az1
functions as an inhibitory protein that targets its enzyme
for degradation as well as a negative regulator of
polyamine transport, ii) Az2 possesses very similar prop-
erties to Az1, except that it does not stimulate degradation
of ODC and iii) Az3 is expressed only during sperma-
togenesis. The bacterial Az (AtoC) functions as an inhibi-
tory protein to ODC, as well as transcriptional regulator
for the two component AtoS-AtoC system. This two com-
ponent system regulates the expression of atoDAEB
operon encoded enzymes, participates in the mechanism
of chemotaxis and regulates the biosynthesis of polyhy-
droxybutyrate, while some other possible roles remain to
be elucidated. Today, under the term antizyme one can
find 22 entries in the SwissProt database and 21 in the
TrEMBL database, respectively. We have proposed possi-
ble functions of this unique protein, but a lot of work
must still be done, in order to understand its pleotropic
role from mammals to archaea and eubacteria. For exam-
ple, we still don't know if Az has a function as a transcrip-
tional regulator in higher organisms and whether its
nuclear localization can be ascribed to such an activity.
Whether phosphorylation of Az plays a role in ODC regu-
lation is also under investigation. Also, a possible role of
polyamines or other catabolic products in activating the
two-component system AtoS-AtoC, which will bring into
interplay two apparently unrelated biological pathways,
i.e short chain fatty acid catabolism and polyamine bio-
synthesis, remains to be elucidated. Uncertainties within
some areas concerning the actual role of Az must be fur-
ther clarified before it can be considered worthwhile to
extend the scope of research in this particular area.
Abbreviations
Az, antizyme; ODC, ornithine decarboxylase; ADC,
arginine decarboxylase
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